Pathological role of immunoproteasome PSMB8 in Parkinson's disease: a link between α-synuclein aggregation and immune activation
Open Access
- 30 October 2025
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 121, 105990
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute
- Korea Ministry of Education (RS-2023-00246655)
- Korea Ministry of Health and Welfare (RS-2023-00265159)
- National Research Foundation of Korea
- National Research Foundation
- Hallym University
- Ministry of Science and ICT, South Korea (2022R1A2C2091254, RS-2023-00223501)
This publication has 34 references indexed in Scilit:
- The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosisCell, 2025
- Single‐extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron‐derived EVsJournal of Extracellular Vesicles, 2024
- The Movement Disorder Society Criteria for the Diagnosis of Multiple System AtrophyMovement Disorders, 2022
- Immunoproteasome is up-regulated in rotenone-induced Parkinson’s disease rat modelNeuroscience Letters, 2020
- Single-Cell Transcriptomics of Parkinson’s Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress ResponsesCell Reports, 2020
- Solo: Doublet Identification in Single-Cell RNA-Seq via Semi-Supervised Deep LearningCell Systems, 2020
- Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation DisordersEBioMedicine, 2018
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 2017
- The New Diagnostic Criteria for Parkinson's Disease2017
- UCHL1 is a Parkinson's disease susceptibility geneAnnals of Neurology, 2004